Effects of Nintedanib on Quantitative Lung Fibrosis Score in Idiopathic Pulmonary Fibrosis

BACKGROUND: Nintedanib slows disease progression in patients with Idiopathic Pulmonary Fibrosis (IPF) by reducing decline in Forced Vital Capacity (FVC). The effects of nintedanib on abnormalities on high-resolution computed tomography scans have not been previously studied. OBJECTIVE: We conducted...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Open Respir Med J
Glavni autori: Lancaster, Lisa, Goldin, Jonathan, Trampisch, Matthias, Kim, Grace Hyun, Ilowite, Jonathan, Homik, Lawrence, Hotchkin, David L., Kaye, Mitchell, Ryerson, Christopher J., Mogulkoc, Nesrin, Conoscenti, Craig S
Format: Artigo
Jezik:Inglês
Izdano: Bentham Science Publishers 2020
Teme:
Respiratory Medicine
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7539538/
https://ncbi.nlm.nih.gov/pubmed/33088361
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1874306402014010022
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items